Cargando…

Oxidative Damage to RNA in Neurodegenerative Diseases

Since 1999, oxidative damage to RNA molecules has been described in several neurological diseases including Alzheimer's disease, Parkinson's disease, Down syndrome, dementia with Lewy bodies, prion disease, subacute sclerosing panencephalitis, and xeroderma pigmentosum. An early involvemen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nunomura, Akihiko, Honda, Kazuhiro, Takeda, Atsushi, Hirai, Keisuke, Zhu, Xiongwei, Smith, Mark A., Perry, George
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2006
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1559934/ https://www.ncbi.nlm.nih.gov/pubmed/17047315 http://dx.doi.org/10.1155/JBB/2006/82323

Ejemplares similares

Sublethal RNA Oxidation as a Mechanism for Neurodegenerative Disease
por: Castellani, Rudy J., et al.
Publicado: (2008)

RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs
por: Nunomura, Akihiko, et al.
Publicado: (2020)

Neurodegenerative Diseases: Mechanisms and Therapies
por: Smith, Mark A., et al.
Publicado: (2006)

Neurofilamentopathy in Neurodegenerative Diseases
por: Liu, Quan, et al.
Publicado: (2011)

Treatment advances in Alzheimer's disease based on the oxidative stress model
por: Friedlich, Avi L, et al.
Publicado: (2009)

Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer Disease
por: Clark, Timothy A., et al.
Publicado: (2010)

Endoplasmic reticulum-mitochondria tethering in neurodegenerative diseases
por: Liu, Yi, et al.
Publicado: (2017)

Oxidative stress, mitochondrial damage and neurodegenerative diseases
por: Guo, Chunyan, et al.
Publicado: (2013)

Role of RNA Oxidation in Neurodegenerative Diseases
por: Liu, Ziqian, et al.
Publicado: (2020)

The interactions of dopamine and oxidative damage in the striatum of patients with neurodegenerative diseases
por: Li, Huifangjie, et al.
Publicado: (2019)

Oxidative Stress, DNA Damage, and c-Abl Signaling: At the Crossroad in Neurodegenerative Diseases?
por: Gonfloni, Stefania, et al.
Publicado: (2012)

Damaged mitochondria coincide with presynaptic vesicle loss and abnormalities in alzheimer’s disease brain
por: Wang, Wenzhang, et al.
Publicado: (2023)

Oxidative Stress and Mitochondrial Damage in Neurodegenerative Diseases: From Molecular Mechanisms to Targeted Therapies
por: Cenini, Giovanna, et al.
Publicado: (2020)

The Role of Neuroinflammation in Cellular Damage in Neurodegenerative Diseases
por: Muthuraju, Sangu, et al.
Publicado: (2020)

Oxidative stress in neurodegenerative diseases☆
por: Chen, Xueping, et al.
Publicado: (2012)

Oxidative Stress in Neurodegenerative Diseases
por: Niedzielska, Ewa, et al.
Publicado: (2015)

Oxidative Stress in Neurodegenerative Diseases
por: Domanskyi, Andrii, et al.
Publicado: (2022)

Heme Deficiency in Alzheimer's Disease: A Possible Connection to Porphyria
por: Dwyer, Barney E., et al.
Publicado: (2006)

Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches
por: Castellani, Rudy J., et al.
Publicado: (2009)

Exploring Molecular Targets for Mitochondrial Therapies in Neurodegenerative Diseases
por: Plascencia-Villa, Germán, et al.
Publicado: (2023)

Plasma sphingolipid abnormalities in neurodegenerative diseases
por: Oizumi, Hideki, et al.
Publicado: (2022)

Mechanisms of DNA damage‐mediated neurotoxicity in neurodegenerative disease
por: Welch, Gwyneth, et al.
Publicado: (2022)

RNA metabolism in neurodegenerative disease
por: Liu, Elaine Y., et al.
Publicado: (2017)

Oxidative Stress in Neurodegenerative Diseases and Ageing
por: Pereira, Marcos D., et al.
Publicado: (2012)

The Role of Oxidative Stress in Neurodegenerative Diseases
por: Kim, Geon Ha, et al.
Publicado: (2015)

Mitochondrial Drugs for Alzheimer Disease
por: Bonda, David J., et al.
Publicado: (2009)

Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters
por: Lee, De-Hyung, et al.
Publicado: (2012)

siRNA Therapeutics: Future Promise for Neurodegenerative Diseases
por: Amiri, Atefeh, et al.
Publicado: (2021)

Phosphorylation of Tau Protein as the Link between Oxidative Stress, Mitochondrial Dysfunction, and Connectivity Failure: Implications for Alzheimer's Disease
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2013)

The Role of the Microbiota–Gut–Brain Axis and Antibiotics in ALS and Neurodegenerative Diseases
por: Obrenovich, Mark, et al.
Publicado: (2020)

Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease
por: Su, Bo, et al.
Publicado: (2009)

Cerium Oxide Nanoparticles Reduce Microglial Activation and Neurodegenerative Events in Light Damaged Retina
por: Fiorani, Lavinia, et al.
Publicado: (2015)

Implications of glial nitric oxide in neurodegenerative diseases
por: Yuste, Jose Enrique, et al.
Publicado: (2015)

Oxidative stress in neurodegenerative disease: causation or association?
por: Van Raamsdonk, Jeremy M., et al.
Publicado: (2017)

An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases
por: Teleanu, Daniel Mihai, et al.
Publicado: (2022)

Proteomic Approaches to Study Cysteine Oxidation: Applications in Neurodegenerative Diseases
por: Pham, Trong Khoa, et al.
Publicado: (2021)

Preclinical progression of neurodegenerative diseases
por: Katsuno, Masahisa, et al.
Publicado: (2018)

Alzheimer Disease and Oxidative Stress
por: Perry, George, et al.
Publicado: (2002)

Amyloid Beta and Tau Proteins as Therapeutic Targets for Alzheimer's Disease Treatment: Rethinking the Current Strategy
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2012)

Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
por: Wang, Wenzhang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j7nb891gc2h1s3lsjhc2b3j2et